ليتروزول
| Kind | API |
|---|---|
| Class | Endocrine oncology — non-steroidal aromatase inhibitor |
| Synonyms | CGS 20267 |
| Common uses / forms | Film-coated tablets 2.5 mg; postmenopausal breast cancer |
| Properties | BCS Class II (practically insoluble, high permeability); low-dose (2.5 mg); polymorphic (Form A/B) |
| Compendia | USP, EP, BP, IP |
| Sourcing origins | India, China |
| Dominant inbound route | Hormuz |
| Indicative price band | $$$$ (> $1000 / kg) |
| Indicative lead time | medium (50–80 days) |
| Notes | Polymorph (stable Form B) control; high-potency hormone containment; low dose drives content-uniformity focus. |
Open the interactive Data Bank (363 substances) · the full table · Supply Resilience Studio
Share: LinkedIn · X · WhatsApp · Telegram · Email
Cite as: AUPAM Experts' Office, Letrozole — sourcing profile (API) — AUPAM Data Bank, retrieved 2026-08-31, https://aupameo.org/datasets/databank/a-letrozole.html